SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the value of pursuing different vaccine strategies. Vaccines based on whole viruses, a widely used vaccine technology, depend on efficient virus production. This study aimed to establish SARS-CoV-2 production...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Autores principales: Offersgaard, Anna, Duarte Hernandez, Carlos Rene, Pihl, Anne Finne, Costa, Rui, Venkatesan, Nandini Prabhakar, Lin, Xiangliang, Van Pham, Long, Feng, Shan, Fahnøe, Ulrik, Scheel, Troels Kasper Høyer, Ramirez, Santseharay, Reichl, Udo, Bukh, Jens, Genzel, Yvonne, Gottwein, Judith Margarete
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310283/
https://ncbi.nlm.nih.gov/pubmed/34209694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070706
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares